Unsuspected Uterine Sarcoma in an Urban Hospital: Does Surgical Approach Matter?

[1]  Yanting Wang,et al.  Incidence of Occult Uterine Pathology in Women Undergoing Hysterectomy With Pelvic Organ Prolapse Repair , 2016, Female pelvic medicine & reconstructive surgery.

[2]  Jason D. Wright,et al.  Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation. , 2016, Journal of minimally invasive gynecology.

[3]  P. G. Paul,et al.  Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience. , 2016, Journal of minimally invasive gynecology.

[4]  Jason D. Wright,et al.  Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids , 2016, Clinical obstetrics and gynecology.

[5]  P. Vercellini,et al.  Prevalence of unexpected leiomyosarcoma at myomectomy: a descriptive study. , 2016, American journal of obstetrics and gynecology.

[6]  T. Raine-Bennett,et al.  Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation , 2016, Obstetrics and gynecology.

[7]  D. Richardson,et al.  Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications , 2015, Obstetrics and gynecology.

[8]  S. As-Sanie,et al.  Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation. , 2016, American journal of obstetrics and gynecology.

[9]  J. Lang,et al.  Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation , 2015, International Journal of Gynecologic Cancer.

[10]  Q. Yang,et al.  Incidence and clinical characteristics of unexpected uterine sarcoma after hysterectomy and myomectomy for uterine fibroids: a retrospective study of 10,248 cases , 2015, OncoTargets and therapy.

[11]  B. Mol,et al.  Surgical approach to hysterectomy for benign gynaecological disease. , 2015, The Cochrane database of systematic reviews.

[12]  J. Lang,et al.  Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy , 2015, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[13]  M. Hoffman,et al.  Morcellation and the Incidence of Occult Uterine Malignancy: A Dual-Institution Review , 2015, International Journal of Gynecologic Cancer.

[14]  J. Berek,et al.  The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis , 2015, Gynecological Surgery.

[15]  J. Kennedy,et al.  Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation. , 2015, American journal of obstetrics and gynecology.

[16]  X. Guo,et al.  Alterations in surgical technique after FDA statement on power morcellation. , 2015, American journal of obstetrics and gynecology.

[17]  A. Kasarskis,et al.  Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma. , 2015, The oncologist.

[18]  W. Cliby,et al.  Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis. , 2015, Gynecologic oncology.

[19]  R. D. de Wilde,et al.  Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH) , 2015, Archives of Gynecology and Obstetrics.

[20]  M. Lieng,et al.  Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women. , 2015, Journal of minimally invasive gynecology.

[21]  S. As-Sanie,et al.  Unexpected Gynecologic Malignancy Diagnosed After Hysterectomy Performed for Benign Indications , 2015, Obstetrics and gynecology.

[22]  B. Slomovitz,et al.  Incidental power morcellation of malignancy: a retrospective cohort study. , 2015, Gynecologic oncology.

[23]  F. Ghezzi,et al.  Risk of undiagnosed uterine malignancies at the time of robotic supracervical hysterectomy and sacrocolpopexy. , 2015, European urology.

[24]  R. Simon,et al.  Incidental gynecologic neoplasms in morcellated uterine specimens: a case series with follow-up. , 2014, Human pathology.

[25]  Aagl Advancing Minimally Invasive Gynecology Worldwide.  AAGL practice report: Morcellation during uterine tissue extraction. , 2014, Journal of minimally invasive gynecology.

[26]  T. Krivak,et al.  Occult uterine cancer in patients undergoing laparoscopic hysterectomy with morcellation , 2012 .

[27]  Sun-Kyung Park,et al.  The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. , 2011, Gynecologic oncology.

[28]  Aagl Advancing Minimally Invasive Gynecology Worldwide.  AAGL position statement: route of hysterectomy to treat benign uterine disease. , 2011, Journal of minimally invasive gynecology.

[29]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.